Substance use disorder and a mental health condition can develop together—we call this dual diagnosis, and it’s common, treatable, and no one’s fault. In the nervous system, shared dopamine reward pathways and stress circuitry link both conditions; anxiety or trauma can drive substance use as a way of coping. At Blue Sails, our providers treat co-occurring conditions together through integrated outpatient care: therapy such as CBT and DBT, relapse prevention, and medication decisions made with a prescriber. These conditions interact, so the plan has to address both. This guide is part of our anxiety and depression care resources, because mood and anxiety symptoms are among the most common companions of substance use. If you are in crisis, call 911, go to the nearest ER, or call or text 988. Below, we walk through signs, screening and treatment options.
What Is Substance Use Disorder?
Substance use disorder (SUD) is a treatable health condition involving a problematic pattern of using alcohol, opioids, stimulants, cannabis or other substances. Alcohol use disorder is the most common form. In the DSM-5, the diagnostic manual used in the United States, providers look at 11 criteria over a 12-month period:
- Using more, or for longer, than intended.
- Wanting to cut down or control use without being able to.
- Spending a lot of time getting, using or recovering from the substance.
- Cravings or strong urges to use.
- Falling behind on responsibilities at work, school or home.
- Continuing to use despite problems in relationships.
- Giving up or cutting back on important activities.
- Using in situations where it is physically dangerous.
- Continuing to use despite a physical or mental health problem it is likely causing or worsening.
- Tolerance: needing more to get the same effect.
- Withdrawal: symptoms when stopping, or using to avoid them.
Two or three criteria suggest a mild disorder, four or five moderate, and six or more severe. This list is for understanding, not self-diagnosis; only a qualified provider can make a diagnosis. Common substances include alcohol, prescription pain relievers, stimulants, cannabis and illicit drugs.
Key Takeaways
- Dual diagnosis means meeting criteria for at least one mental health condition and one substance use disorder simultaneously, regardless of which came first.
- Many adults with a mental health condition also have a substance use disorder; the overlap is substantial but not universal.
- Shared risks—trauma, stress, inherited vulnerabilities—and overlapping brain reward pathways link both conditions; substances are sometimes used to cope with distress.
- Integrated treatment addresses both conditions at once through combined assessment, medication, psychological care, and relapse prevention rather than treating each separately.
- Neuroplasticity allows the brain to change; cognitive behavioral therapy builds coping skills, modifies learned behaviors, and can support recovery.
What Dual Diagnosis Really Means
Dual diagnosis—often called co-occurring disorders—isn’t one specific condition; it’s the clinical shorthand we use when a person meets criteria for at least one mental health condition and at least one substance use disorder at the same time. The term covers many combinations—depression with alcohol use disorder, PTSD alongside opioid dependence. It doesn’t specify severity, cause, or a treatment plan, and it doesn’t tell us which came first. Shared risks like trauma, stress, and inherited vulnerabilities shape both conditions; some people use substances to cope with anxiety, depression, or pain. An integrated approach addresses both conditions together and can support relapse prevention. Cognitive behavioral treatment can help people modify learned behaviors and build coping skills to resist substance use.
Symptoms interact, so we assess both together. Personality disorders can also co-occur with addiction and may complicate recovery, making integrated treatment important. Trauma-related changes in stress responses may increase vulnerability to substance use. Detoxification (supervised withdrawal management) may be the first step for some people with physical dependence. Blue Sails does not provide detox onsite; we assess withdrawal risk and help you connect with the right level of care when outpatient care alone isn’t safe.
How Common Are Co-Occurring Disorders?
You don’t have to look far for reassurance that co-occurring disorders are common—there’s a good chance someone you know is living with one. National surveys from SAMHSA find that a large share of adults with a mental health condition also have a substance use disorder, and the overlap is higher among people with more serious symptoms. The overlap is substantial but not universal, and young adults are among the groups most affected. Knowing how common this is means recognition, not rarity. Anxiety, depression, and PTSD travel alongside substance use. Research in veterans suggests PTSD symptoms such as hyperarousal and avoidance may predict future high-risk drug and alcohol use. Research also highlights craving and stress vulnerability as important factors in addiction. A coordinated care approach can help veterans with serious mental health and substance use disorders build more stable lives in their communities. If you’re struggling right now, call 911, go to the nearest ER, or call or text 988 for support.
How Substance Use and Mental Health Conditions Rewire the Brain
When we sit down with clients facing both substance use and mental health challenges, we often begin by explaining how these conditions rewire the brain, because understanding the mechanics replaces shame with clarity. Substance use and mental health conditions draw on the same shared reward pathways that govern pleasure and motivation, while overlapping stress and trauma circuitry can keep the nervous system primed for distress and craving. Dopamine can help neutral cues acquire conditioned rewarding properties, making them more likely to prompt reward-seeking behavior. Substance use disorders can be shaped by a combination of genetic and environmental factors. Stress can also increase vulnerability to addiction by influencing the brain’s reward pathways. Disruptions in dopamine signaling can affect motivation and reinforce substance-seeking behavior. Here’s the hopeful part: neuroplasticity means the brain can change again, and evidence-based treatments like CBT can help build new patterns that support recovery.
Shared Reward Pathways
The brain’s reward system sits at the heart of why substance use disorders and mental health conditions often show up together. This mesocorticolimbic network—linking the ventral tegmental area, nucleus accumbens, and prefrontal regions—helps us feel motivated and learn what matters. The medial prefrontal cortex also helps regulate emotional behavior and autonomic responses, linking brain circuits to mood. Dopamine isn’t simply a pleasure chemical; it flags what’s important and reinforces behaviors. Addictive substances can drive a much larger dopamine surge than natural rewards, making drug cues feel unusually salient. Over time, receptors downregulate, ordinary joys fade, and tolerance builds; craving follows learned cues. Substance use disorders can involve multiple substances, including alcohol and other drugs. We see parallel patterns in depression, schizophrenia, and ADHD, where reward processing differs too. Dopamine receptor subtypes and their signaling pathways can shape unconditioned psychomotor behavior. These shared circuits offer one biological link—not a single cause. Understanding them helps us replace shame with effective care. Early intervention can support timely diagnosis and treatment, including medication and psychological care.
Stress and Trauma Circuitry
Reward circuits tell only part of the story—stress and trauma circuitry completes it. When we face threat, our hypothalamic–pituitary–adrenal (HPA) axis releases CRH, cortisol, and norepinephrine. In a person with PTSD and substance use disorder, this system can become sensitized. The amygdala’s fear response intensifies while the prefrontal cortex and hippocampus—our brakes on alarm—lose influence. High cortisol during trauma strengthens emotional memory, and repeated substance use recruits CRF signaling in the extended amygdala, fueling anxiety-like states. Substances temporarily quiet that alarm, so seeking relief makes sense—it’s coping, not weakness. Research shows this stress activation can persist into abstinence, raising relapse risk. Fear-conditioning and extinction tasks can help researchers study how the brain learns safety after threat. These models help researchers investigate fear extinction and its role in PTSD. Sympathetic activation can also contribute to the body’s fight-or-flight response to perceived threats. PTSD research also examines how fear circuitry may inform new treatment approaches. If distress feels overwhelming, call 911, go to the nearest ER, or call or text 988 for immediate support. Trauma-focused therapies such as CBT, EMDR and CPT are designed to work on these patterns gradually and safely.
Neuroplasticity in Dual Diagnosis
Dual diagnosis means two learning processes reshaping one brain—and that’s not a character flaw, it’s neuroplasticity at work. Repeated substance exposure rewires reward circuits in the ventral tegmental area and nucleus accumbens, so drug cues feel urgent while everyday rewards fade. Weakened prefrontal control loses ground to striatal habit systems—that’s why willpower alone rarely wins. Co-occurring depression or PTSD reshapes overlapping limbic networks, so we don’t assume one universal brain profile—imaging shows group patterns, not individual diagnoses. Genetic vulnerability can interact with life experiences and other nongenetic factors in the development of mood disorders. Inherited vulnerability is one part of a complex picture. Gender differences can also shape addiction’s progression and treatment outcomes, underscoring the importance of individualized care. Ovarian hormones such as estrogen and progesterone and their metabolites can influence substance-related behaviors and treatment responses. Gender-sensitive care can account for social factors that shape mental health and recovery. Thankfully, the same plasticity that built these patterns can gently unbuild them. Imaging research suggests some brain changes can partly recover after sustained abstinence. Therapies such as CBT and EMDR aim to build on this capacity for change. From an evolutionary perspective, motivational systems can help explain why substances produce different experiences and why addiction risk varies between individuals.
Why Tolerance and Withdrawal Feed the Co-Occurring Cycle
When tolerance develops, the same amount of a substance stops delivering the relief it once did, and that fading effect can pressure a person toward higher doses and greater risk. Withdrawal then adds its own weight—anxiety, depressed mood, and physical distress can surface during this time, overlapping with mental health symptoms and making everything feel harder to untangle. We want you to know this isn’t a character flaw; it’s a predictable nervous system pattern we see often in our work, and it’s one we can help interrupt with careful assessment and evidence-based support. Care can range from weekly outpatient therapy to more intensive or medically supervised programs. We assess what level of care fits your situation and, when you need more support than outpatient care provides, help you connect with it. Our guide to intensive outpatient programs (IOP) explains how that level of care works. For some people, medication for a substance use disorder is part of the plan; that decision is made with a prescriber.
Tolerance Drives Escalating Use
If you’ve noticed that a substance doesn’t affect you the way it used to, your brain has adapted—and that adaptation has a name: tolerance. We see this often: repeated exposure reduces the brain’s responsiveness, so the original “high” fades. Many substances flood the reward circuit with dopamine, reinforcing use; as effects weaken, taking more becomes an attempt to recapture what once came easily. Over time, these changes can affect judgment and decision-making, making limits harder to hold. We want you to know tolerance alone doesn’t mean you have a substance use disorder—but escalating use, especially alongside struggling to meet responsibilities, is a warning sign worth taking seriously. Prevention strategies can help reduce substance-related harms and support earlier access to care. Substance use can also affect mental health and make recovery more complex. Addiction is influenced by multiple factors, including biological, psychological, and social influences. We can help you sort it out with real compassion, and recovery remains entirely possible.
Withdrawal Intensifies Mental Symptoms
Because the brain has already adapted around a substance, its absence can feel like a mental health crisis—sometimes worse than what you were using to manage. We see this often: alcohol withdrawal brings anxiety, irritability, and insomnia; stimulant withdrawal can trigger depression, fatigue, and paranoia; opioid withdrawal adds anxiety to nausea and muscle pain. These symptoms don’t mean you’re failing—they’re your nervous system recalibrating.
| Substance | Withdrawal Often Feels Like | How Long It Can Last |
|---|---|---|
| Alcohol | Anxiety, irritability, insomnia, poor concentration | Often eases within about a week; severe alcohol withdrawal can be dangerous and needs medical care |
| Stimulants | Depression, fatigue, paranoia, sleep changes | Low mood and fatigue can linger; watch closely for depression or thoughts of suicide |
| Opioids | Anxiety alongside nausea and muscle pain | Usually days to a week or more; a prescriber can help manage symptoms |
That distress can drive use back up. We assess withdrawal risk carefully and, when needed, refer you to medically supervised withdrawal care at the right level of care. Therapy such as CBT can continue as symptoms ease. Severe alcohol withdrawal needs medical care. Early attention to psychological distress and interpersonal problems may help reduce treatment dropout. A careful assessment considers DSM-5 criteria to help identify alcohol use disorder and guide treatment.
Why Untreated Mental Health Symptoms Fuel Self-Medication
Although self-medication often gets dismissed as weak willpower, we recognize it as something far more human: an attempt to quiet real suffering.
When anxiety, depressed mood, insomnia, or trouble concentrating go untreated, they keep the nervous system on high alert. Alcohol or other drugs offer fast, temporary relief, and that relief teaches the brain to repeat the behavior. It’s negative reinforcement, not a character flaw. Recovery programs can strengthen peer support and empower people to take an active role in their care. A study of the Wellness Recovery Action Plan found significant improvements in psychiatric symptoms and hope.
The cycle deepens as tolerance builds, and use shifts from coping toward avoiding cravings or withdrawal. Substances can also worsen the very symptoms they soothe, and rebound effects can mimic them, muddying the picture. National survey data from SAMHSA show that many adults with co-occurring conditions receive no treatment for either. Coordinated assessment and integrated treatment can help interrupt this pattern.
PTSD and Substance Use: Breaking the Trauma Loop
When trauma leaves the nervous system stuck in survival mode, many people reach for alcohol or drugs to quiet symptoms that never switch off—which is one reason PTSD and substance use disorders so often occur together. We call this the trauma loop: distress fuels use, use deepens avoidance, and untreated trauma keeps relapse risk high even when only one condition gets care. The good news is that trauma-informed integrated treatment—pairing evidence-based PTSD therapies like CPT or EMDR with substance use relapse-prevention—lets us address both together and work on breaking the cycle. However, medication adherence remains low among people with PTSD, particularly those with substance or alcohol use disorders. Among recent combat Veterans with PTSD symptoms and hazardous alcohol use, social support was one factor associated with outpatient mental health care use over 12 months.
Trauma and Self-Medication
Why does a drink, a pill, or a drug feel like the only thing that quiets a nervous system stuck on high alert?
We see this pattern often. After trauma, the brain stays threat-ready: intrusive memories, restless nights, constant tension. Substances blunt that distress quickly, and removing discomfort reinforces use through negative reinforcement. That’s the self-medication loop, not moral weakness. Research shows people with PTSD face higher odds of developing a substance use disorder.
Consider what that relief costs:
- Numbing the memories also numbs connection with people you love.
- Each drink teaches your brain that feelings are threats.
- Withdrawal mimics hyperarousal, restarting the very alarm you’re escaping.
Please hear this: the loop is learned, not chosen, and it can change.
Trauma-Informed Integrated Treatment
The self-medication loop ends the same way it started: through the nervous system, not against it. That’s why we treat PTSD and substance use together, not one after the other. Research reviews suggest that integrated, trauma-focused care may work better than treating each condition separately. Approaches like COPE, Prolonged Exposure, Cognitive Processing Therapy, and EMDR pair trauma work with relapse-prevention skills.
You don’t need to be abstinent first; a substance use diagnosis doesn’t disqualify you from trauma treatment. Evidence doesn’t support withholding care over fears it will worsen use, and many people with PTSD and substance use disorder can tolerate trauma-focused treatment. We move at your pace, prioritizing safety, choice, and full transparency while monitoring both conditions carefully. If distress feels overwhelming, call 911, go to the nearest ER, or call or text 988.
ADHD and Addiction: The Overlooked Dual Diagnosis
Although ADHD and substance use disorder co-occur far more often than chance alone would predict, the connection gets missed in both directions, making this one of behavioral health’s most overlooked dual diagnoses.
Research finds ADHD is common among adults entering substance use treatment, and ADHD is linked with higher risk of nicotine, alcohol and drug use problems.
- A teen struggling to focus discovers substances quiet the noise, then dependence arrives years before anyone asks about ADHD.
- Some adults are labeled “treatment-resistant” for years when untreated ADHD may be getting in the way of recovery.
- ADHD can be linked with faster progression to dependence, which is why early screening matters.
If attention or focus has been a lifelong struggle, our ADHD and neurodivergence page explains how assessment works.
Anxiety, Bipolar Disorder, and Substance Use
Anxiety and bipolar disorder frequently overlap with substance use, and understanding why helps us replace shame with a clearer path forward. When anxiety symptoms overwhelm the nervous system, many people reach for alcohol or other substances to calm it—a coping pattern we call self-medication—while many people living with bipolar disorder experience a co-occurring substance use disorder at some point in their lives. Because intoxication and withdrawal can mimic mood and anxiety symptoms, we screen carefully to untangle what’s driving what, then build integrated treatment that addresses both conditions together.
Anxiety and Self-Medication
Many people discover—often quietly, and with real shame—that alcohol, cannabis, or benzodiazepines seem to quiet their anxiety faster than anything else. We want you to know this isn’t a character flaw; it’s your nervous system seeking relief, and it’s remarkably common.
Here’s the trap: short-term calm often triggers rebound anxiety, which fuels the next use. Consider what research shows:
- Long-term studies suggest that people with anxiety who use alcohol to cope are more likely to develop a new alcohol use disorder than those who don’t.
- Using alcohol to self-medicate has been linked with higher odds of developing alcohol dependence.
- Using drugs to self-medicate has been linked with higher odds of drug dependence.
We treat both together. Through integrated care, CBT can help retrain anxious thought patterns while we address substance use, so you can build steadier ways to cope. Learn more about our anxiety and depression care.
Bipolar Disorder and Substances
Research consistently finds that substance use disorders are much more common in people with bipolar disorder than in the general population. Alcohol use disorder is the most common, followed by cannabis.
Substance use shapes the illness course: cannabis use disorder accompanies more manic episodes, rapid cycling, psychosis, and earlier onset, while alcohol use disorder worsens depression, treatment response, medication adherence, and suicidality.
That’s why we don’t screen for alcohol alone; we ask about cannabis, stimulants, cocaine, and past use, addressing both conditions together. If distress feels unbearable, call 911, go to the nearest ER, or call or text 988.
Recognizing Overlapping Symptoms
Bipolar disorder rarely shows up alone—and neither do anxiety or substance use. We see this overlap constantly: anxiety, irritability, mood shifts, agitation, sleep changes, and unusual energy can belong to more than one condition, which makes professional evaluation essential. Consider what we watch for together:
- Anxiety that persists—chronic worry about work, money, or relationships lasting six months or more—can also emerge from withdrawal, so context matters.
- Mania’s rapid speech, risk-taking, and agitation can mirror substance effects, blurring the line.
- Continued use despite harm—damaged relationships, failing health, lost work—signals a substance use disorder needing care.
Overlapping symptoms aren’t moral failures; they’re nervous system signals worth decoding with a trained provider.
Which Came First: The Substance Use or the Mental Health Condition?
When clients ask us whether their substance use caused their mental health condition—or the other way around—we usually start with the honest answer: there’s often no single starting point, and that’s okay. Depression, PTSD, or anxiety can lead someone to use substances to cope; substance use can also trigger or worsen psychiatric symptoms, and shared risks like trauma or genetics shape both.
| Possible Pattern | What It Looks Like | Why It Matters |
|---|---|---|
| Mental health condition first | Coping with distress through alcohol or drugs | Temporary relief often deepens symptoms |
| Substance use first | Use triggers or mimics anxiety, depression, or psychosis | Stopping substances may clarify symptoms |
| Shared roots | Trauma, genetics, chronic stress fuel both | Neither condition is “to blame” |
Whatever the order, we treat both conditions together.
Why Dual Diagnosis Gets Missed (and How Screening Helps)
Dual diagnosis gets missed more often than it should, and we want you to understand why—because it’s rarely about anyone failing. Overlapping symptoms mask diagnosis since substance use and mental health conditions affect many of the same nervous system pathways, producing similar anxiety, low mood, and sleep problems that are hard to tell apart, while stigma delays honest disclosure when someone fears judgment for sharing how much they’re drinking or using. That’s why we screen for both conditions together—at intake and throughout care—so we can see the full picture early and connect you with treatment that addresses everything that’s actually going on. This approach reflects SAMHSA’s no wrong door policy, which ensures that anyone presenting for mental health treatment is routinely screened for substance use disorder, and anyone presenting for substance use treatment is screened for mental health conditions.
Overlapping Symptoms Mask Diagnosis
Because intoxication and withdrawal directly alter brain chemistry, they can produce mood swings, anxiety, irritability, insomnia, and even perceptual disturbances that look nearly identical to primary mental health symptoms—and that overlap is one of the main reasons co-occurring disorders go unrecognized. That’s why we don’t diagnose during intoxication or withdrawal alone. We watch for three interactions:
- Mimicking—substance effects can imitate depression, anxiety, or psychosis, earning someone a wrong label.
- Masking—alcohol or drugs can hide symptoms you’ve carried for years.
- Compounding—conditions feed each other, becoming more persistent and treatment-resistant than either alone.
Timing matters: when did symptoms start, and how do they relate to use? Observation after abstinence often brings clarity. We screen routinely for both, so less gets missed.
Stigma Delays Honest Disclosure
Although walking into a therapy office takes courage, stigma often convinces people to hold back the very information that helps us most. Research shows that many adults in substance use treatment have held back information about their use, and internalized shame makes that silence more likely. We see why. Fear of judgment, reputational harm, or a provider’s cold reaction makes honesty feel risky, so people minimize symptoms or stay quiet until trust develops. But concealment leaves us working with partial information, unable to recognize co-occurring concerns or offer appropriate follow-up. You don’t need to share everything at once. We build trust gradually, explain privacy protections, and let disclosure unfold at your pace.
Screening Both Conditions Together
When symptoms overlap, even skilled providers can miss what’s really going on. Depression can hide behind drinking; anxiety can fuel substance use. If we only treat what we see first, the second condition stays buried.
That’s why we screen both conditions together—it’s a “no wrong door” approach. Consider what’s at stake:
- A person seeking help for depression may never be asked about alcohol use.
- A person entering substance use treatment may carry undiagnosed PTSD or anxiety.
- Without routine rescreening, conditions that emerge later go untreated.
Screening isn’t labeling or judgment. A positive screen simply means “let’s look closer” through thorough assessment. Tools like the PHQ-9, GAD-7, and AUDIT help us see the whole person, so we can treat both conditions together—not in isolation.
Why Do So Many Co-Occurring Disorders Go Untreated?
Many adults living with both a mental health condition and a substance use disorder receive treatment for neither one. We see this gap every day, and it’s rarely about unwillingness. Most people face layered barriers:
| Barrier | How it sounds |
|---|---|
| Self-reliance | “I should handle this myself.” |
| Cost | “Therapy costs too much.” |
| Stigma | “What will people think?” |
| Logistics | “I don’t know where to start.” |
Among adults who feel they need care, many believe they should manage substance use alone, and many cite cost. Add transportation, childcare, and fear of judgment, and waiting feels safer than reaching out. None of this means you’re broken—it means help hasn’t felt reachable. Naming these barriers is the first step toward care.
Why Separate Treatment Fails Co-Occurring Disorders
If you’ve ever bounced between a mental health clinic and an addiction program, you already know the flaw in separate treatment: no single door opens onto the whole problem. We see the cost of fragmented care every day, and it rarely comes from lack of effort on your part. It comes from systems that weren’t built for people living with both conditions at once:
- Gaps that exhaust you—sequential referrals delay care, and many people disengage while waiting.
- Messages that contradict each other—one team treats depression while another addresses substance use, leaving a condition unattended.
- Treatment that keeps failing—untreated symptoms fuel relapse, dropout, and hospitalization.
We want you to know this clearly: your struggle reflects broken systems and coordination, not broken character.
How Integrated Dual Diagnosis Treatment Works
Integrated dual diagnosis treatment answers that broken-systems problem with a different architecture: one team, one plan, one door.
We screen for mental health and substance use conditions together, at intake and throughout care, because either condition can reveal the other. We assess symptoms, substance patterns, treatment history, safety, physical health, and daily functioning, then build one combined plan.
Our providers coordinate therapy and case reviews and work with your prescriber on medication decisions, so you’re never translating between providers who don’t communicate. When housing, medical, or legal needs affect recovery, we link those supports too.
Treatment follows your stage of recovery (engagement, active treatment, relapse prevention), adjusting as needs change. When medication is part of the plan, it is decided with a prescriber and combined with therapy such as CBT, with safety and response monitored along the way. Research generally supports integrated care for people with co-occurring conditions.
Motivational Interviewing: Finding Your Reason to Change
Ambivalence is where most people with substance use concerns actually live—wanting to change and not wanting to, sometimes within the same hour. We don’t treat that as weakness; motivational interviewing treats it as the starting point. Instead of arguing or lecturing, we ask open questions and reflect back what we hear, so your reasons for change come from you, not us. Change tends to stick when it connects to what you value most:
- Watching your kids grow up without missing another moment.
- Rebuilding trust with the people you love.
- Feeling like yourself again—clear, present, hopeful.
Naming the gap between your current path and the life you want builds motivation. Research suggests these collaborative conversations can be more helpful than advice-giving alone, even in brief sessions.
CBT Relapse Prevention for Co-Occurring Disorders
When a mental health condition and substance use travel together, relapse prevention becomes a two-lane road—we can’t treat one lane while ignoring the other. Because co-occurring conditions carry higher relapse rates, we plan for both simultaneously. CBT starts with functional analysis: we map the situations, thoughts, emotions, and consequences that surround use, noticing how depression, anxiety, or trauma symptoms feed the pattern. Next, we build coping skills—cognitive restructuring to reframe unhelpful thoughts, alongside problem-solving, emotion regulation, behavioral activation, sleep, and stress management—all tailored to your specific condition, not a generic template. A lapse isn’t failure; it’s information. We review what happened, update your plan, and coordinate ongoing supports before treatment ends. Identifying warning signs early keeps high-risk moments from surprising you.
Urge Surfing: Riding Out Cravings and Emotional Urges
How do you ride out a craving without obeying it? We teach urge surfing, a mindfulness skill that helps you notice urges without suppressing or acting on them. Cravings aren’t commands—they’re waves that rise, peak, and fall. When we observe them instead of fighting, we discover they’re temporary.
Here’s how we practice it:
- Pause and notice your breath without changing it.
- Locate the urge in your body—its intensity, edges, and shifting qualities.
- Stay with it for at least five breathing cycles, watching it change.
Urge surfing works for substance cravings, overeating, spending, and lashing out. Research suggests it can help separate craving from using. It’s a coping tool, not a replacement for individualized dual diagnosis treatment—we’re here to help you build both.
Medication Options in Dual Diagnosis Care
The fear that medication will simply trade one dependence for another keeps many people from treatment that could help. We recognize that worry, and we’ll name it honestly: some medications carry misuse potential, so prescribers weigh risks and monitor closely. But many options don’t. For opioid use disorder, FDA-approved medications such as buprenorphine, methadone and naltrexone can reduce cravings and withdrawal; taken as prescribed, they are not meant to produce the high that fuels the cycle. For alcohol use disorder, medications such as naltrexone and disulfiram can support recovery. Whether any of these fit you is a decision you make with a prescriber. Psychiatric medications that stabilize depression, anxiety, or PTSD symptoms generally remain appropriate alongside substance use treatment; they can help you engage more fully in therapy like CBT. Medication decisions, including any dose changes, are made with your prescriber; our providers coordinate with your prescriber and help watch for interactions. See our medication management page for how this works. One caution: benzodiazepines combined with substance use disorder medications require special care.
What Long-Term Dual Diagnosis Recovery Looks Like
If you’re picturing recovery as a finish line, we want to gently reframe that image: for people with co-occurring substance use and mental health conditions, recovery usually unfolds over years, not weeks, and it rarely moves in a straight line. Long-term follow-up research offers hope: many people with a dual diagnosis improve over time. Within that research, people gained ground in areas such as:
- Independent living and competitive employment
- Friendships with people who don’t use substances
- Managing substance use and psychiatric symptoms
Progress arrived in different orders for different people, and that’s normal. Because life domains like housing, work, and relationships heal on their own timelines, we individualize recovery goals. And a setback doesn’t erase what you’ve built. Continuing care sustains it.
Frequently Asked Questions
Does Insurance Cover Integrated Treatment for Co-Occurring Disorders?
Many health plans include mental health and substance use benefits, but coverage depends on your specific policy. Verify your benefits, confirm in-network providers and check prior-authorization rules before starting treatment. You can also call us at (410) 231-0488 and we can help you check.
How Do I Find a Qualified Dual Diagnosis Provider in Maryland?
Verify each provider’s license with the relevant Maryland licensing board, then ask candidates directly whether they treat substance use and mental health concerns together, and confirm they’re accepting new clients. To ask about care at Blue Sails, call (410) 231-0488.
Can I Receive Dual Diagnosis Treatment Through Telehealth Instead of in Person?
Yes. Blue Sails offers secure telehealth for therapy across Maryland, and medication support is coordinated with a prescriber. We’ll assess whether remote treatment fits your needs, though we may recommend in-person care if your home lacks privacy.
How Can I Support a Loved One Who Refuses Treatment for Co-Occurring Disorders?
We can’t force treatment, so we suggest listening without judgment, offering small voluntary steps, setting firm boundaries, avoiding cover-ups, seeking your own family support, and gently reopening conversations over time. If your loved one is in danger, call 911, go to the nearest ER, or call or text 988. Our crisis help page lists more options.
Is Medical Detox Required Before Starting Outpatient Dual Diagnosis Treatment?
Not always. Blue Sails does not provide detox onsite. We assess your withdrawal risk, and when outpatient care alone isn’t safe, we refer you to medically supervised withdrawal care at the right level of care first. After detox, ongoing integrated dual diagnosis treatment still matters, and we can continue that care with you.